SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs' Ankleshwar factory sealed

04 Jul 2011 Evaluate

Lyka Labs' Ankleshwar factory is sealed without following due procedure of law, by the Mamlatdar of Ankleshwar for alleged recovery of dues towards Drug Price Equalization Account (DPEA), under  Drugs Price Control Order, 1979 (DPCO 1979). This has happened despite the matter being Sub Judice before the Gujarat High Court. The hearing is on in the matter in the Gujarat High Court and the company hopes that the matter will be resolved soon.

Earlier, Lyka Labs factory at Ankleshwar had achieved record production for the month of September, 2010. Its Ankleshwar plant is located in one of the largest chemical Industrial Estates in Asia, in Gujarat. The manufacturing plant has facilities for production of Capsules, External preparations, Parentals and Lyophilizations and the capacity of the plant for capsules is 10 lakh caps per shift, for ointment 1 lakh tubes per shift, for parentals 1 lakh vials of powder injection per shift and for lyophilization 300 kgs condenser and 2 lyophilizers.

Lyka Labs is engaged in manufacturing of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.

The DPCO was first passed in 1970 and then revised in 1979, 1987 and 1995. The DPCO is an order issued by the government empowering it to fix and regulate the prices of essential bulk drugs and their formulations. The Drugs Prices Control Order of 1979 was issued on March 31. In its revised version, the DPCO stipulated ceiling prices for controlled categories of bulk drugs and their formulations.

Lyka Labs Share Price

59.05 0.50 (0.85%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×